Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild

Jing He1, Sarah Farias, Oliver Martinez

  • 1Department of Neurology, and the Imaging of Dementia and Aging Laboratory, Center for Neuroscience Preventive Medicine, University of California at Davis, Sacramento, CA 95817, USA.

Archives of Neurology
|November 11, 2009
PubMed
Abstract

Insights

Mild cognitive impairment (MCI) subtypes show distinct patterns. Amnestic MCI may indicate Alzheimer's pathology, while nonamnestic MCI suggests vascular issues, though all MCI types exhibit brain injury.

Area of Science:

  • Neurology
  • Neuroimaging
  • Geriatrics

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
  • Understanding MCI subtypes is crucial for accurate diagnosis and targeted interventions.
  • Existing research suggests heterogeneity within MCI, necessitating further investigation into its subtypes.

Purpose of the Study:

  • To investigate demographic, neuroimaging (MRI), and vascular risk differences across mild cognitive impairment (MCI) subtypes.
  • To compare these factors between MCI subtypes, cognitively normal controls, and Alzheimer disease patients.

Main Methods:

  • Cross-sectional study involving 153 MCI subjects, 218 controls, and 68 Alzheimer disease patients.
  • MCI subtypes classified based on neuropsychological performance.
  • Vascular risk assessed via medical history; MRI used for brain and hippocampal volumes; apolipoprotein E genotyping performed.

Main Results:

  • Significant differences in brain and hippocampal volumes were observed across control, MCI, and Alzheimer disease groups.
  • Amnestic MCI subtypes showed less brain atrophy and altered hippocampal volumes compared to controls.
  • Apolipoprotein E genotype was more prevalent in amnestic and nonamnestic MCI; nonamnestic subtypes had higher vascular risk and African American prevalence.

Conclusions:

  • Amnestic MCI subtypes exhibit characteristics aligning with Alzheimer disease pathology.
  • Nonamnestic MCI subtypes present findings suggestive of underlying vascular disease.
  • All MCI subtypes demonstrate evidence of brain injury, with subtle biological distinctions beyond memory versus non-memory impairments.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.